Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Clinical Laboratory Improvement Amendments Waiver Applications, 48172 [2013-19053]
Download as PDF
48172
Federal Register / Vol. 78, No. 152 / Wednesday, August 7, 2013 / Notices
ANNUAL BURDEN ESTIMATES
Instrument
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
None ................................................................................................................
1,113,719
1
0.17
189,332.23
Estimated Total Annual Burden
Hours: 189,332.23.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
SUMMARY:
Robert Sargis,
Reports Clearance Officer.
BILLING CODE 4160–01–P
[FR Doc. 2013–19058 Filed 8–6–13; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4184–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES
[Docket No. FDA–2012–N–0937]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Clinical Laboratory Improvement
Amendments Waiver Applications
ACTION:
Food and Drug Administration,
Notice.
VerDate Mar<15>2010
17:03 Aug 06, 2013
Jkt 229001
[FR Doc. 2013–19053 Filed 8–6–13; 8:45 am]
[Docket No. FDA–2012–D–1092]
Food and Drug Administration
HHS.
Dated: August 1, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
Food and Drug Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Clinical Laboratory Improvement
Amendments Waiver Applications’’ has
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
5156, Daniel.Gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On April
23, 2013, the Agency submitted a
proposed collection of information
entitled ‘‘Clinical Laboratory
Improvement Amendments Waiver
Applications’’ to OMB for review and
clearance under 44 U.S.C. 3507. An
Agency may not conduct or sponsor,
and a person is not required to respond
to, a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0598. The
approval expires on July 31, 2016. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
Minimizing Risk for Children’s Toy
Laser Products; Draft Guidance for
Industry and Food and Drug
Administration Staff; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of the draft guidance
entitled ‘‘Minimizing Risk for Children’s
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Toy Laser Products.’’ This draft
guidance is to inform manufacturers of
laser products, FDA headquarters and
field personnel, and the public of the
Center for Devices and Radiological
Health’s (CDRH) proposed approach on
the safety of toy laser products. This
draft guidance is not final nor is it in
effect at this time.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
on the draft guidance by November 5,
2013.
Submit written requests for
single copies of the draft guidance
document entitled ‘‘Minimizing Risk for
Children’s Toy Laser Products’’ to the
Division of Small Manufacturers,
International and Consumer Assistance,
Center for Devices and Radiological
Health, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 66,
rm. 4613, Silver Spring, MD 20993–
0002. Send one self-addressed adhesive
label to assist that office in processing
your request, or fax your request to 301–
847–8149. See the SUPPLEMENTARY
INFORMATION section for information on
electronic access to the guidance.
Submit electronic comments on the
draft guidance to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Identify
comments with the docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Robert J. Doyle, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 4672, Silver Spring,
MD 20993–0002, 301–796–5863.
ADDRESSES:
I. Background
This draft guidance is to inform
manufacturers of laser products, FDA
headquarters and field personnel, and
the public of CDRH’s proposed
approach on the safety of children’s toy
laser products. Lasers with outputs
above certain levels that are operated in
E:\FR\FM\07AUN1.SGM
07AUN1
Agencies
[Federal Register Volume 78, Number 152 (Wednesday, August 7, 2013)]
[Notices]
[Page 48172]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0937]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Clinical Laboratory Improvement
Amendments Waiver Applications
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Clinical Laboratory Improvement
Amendments Waiver Applications'' has been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-5156,
Daniel.Gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: On April 23, 2013, the Agency submitted a
proposed collection of information entitled ``Clinical Laboratory
Improvement Amendments Waiver Applications'' to OMB for review and
clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor,
and a person is not required to respond to, a collection of information
unless it displays a currently valid OMB control number. OMB has now
approved the information collection and has assigned OMB control number
0910-0598. The approval expires on July 31, 2016. A copy of the
supporting statement for this information collection is available on
the Internet at https://www.reginfo.gov/public/do/PRAMain.
Dated: August 1, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-19053 Filed 8-6-13; 8:45 am]
BILLING CODE 4160-01-P